Breaking News

Aptuit Adds to Executive Team

April 11, 2013

Dinkelacker, Duffield bring extensive experience

Aptuit LLC has appointed two new members to its executive leadership team. Kurt Dinkelacker has been named executive vice president and chief financial officer and Kevin Duffield has been promoted to vice president, sales and business development.
Mr. Dinkelacker reports to Stuart Needleman, Aptuit’s president and chief operating officer. Mr. Dinkelacker has extensive experience in managing global financial operations in growth-focused corporations. Previously, he was executive vice president and chief financial officer at Retrievex. He also held leadership positions at Financing Alternatives, TeleSpectrum Worldwide and IKON Office Solutions. 

Mr. Duffield takes on new responsibilities handling global sales and marketing, also reporting to Mr. Needleman. Mr. Duffield has more than 25 years of experience in pharmaceutical contract manufacturing services. He has held several leadership positions in sales, business development, and operations of cGMP development and manufacturing facilities.
Mr. Needleman said, “We congratulate these professionals and look forward to their contributions to our Executive Leadership team. We’ve put a great deal of effort in finding the people who represent our ‘uncommon expertise’ across a range of disciplines. These two proven pros are valuable additions to our team, ready to implement a strategy that will help steer Aptuit to its position as a market-leading provider of early to mid-phase integrated drug discovery and development.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important